Immunological aspects of intravesical administration of Bacillus Calmette-Guérin (BCG) in the guinea pig
✍ Scribed by van der Meijden, A. P. M. ;de Jong, W. H. ;de Boer, E. C. ;Steerenberg, P. A. ;Debruyne, F. M. J. ;Ruitenberg, E. J.
- Publisher
- Springer
- Year
- 1989
- Tongue
- English
- Weight
- 828 KB
- Volume
- 17
- Category
- Article
- ISSN
- 0300-5623
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Intravesical Mycobacterium bovis bacillus Calmette-Gu\*erin (BCG) is the treatment of choice for superficial bladder cancer. Previous studies showed that attachment of BCG to fibronectin within the bladder was necessary for mediation of the antitumor response. Further studies identified a bacterial
Local immunotherapy with bacillus Calmette-Guérin (BCG) is an effective treatment to prevent recurrence and progression of superficial bladder cancer, but the antitumor mechanism of action of BCG remains unclear. There are some experimental and clinical data suggesting that BCG antigens are processe